β€’
Mar 28

Integer Q1 2025 Earnings Report

Integer reported a solid first quarter with strong revenue and adjusted earnings growth despite a GAAP net loss due to debt conversion costs.

Key Takeaways

Integer Holdings posted 7% revenue growth and strong adjusted profitability in Q1 2025, although GAAP net income turned negative due to one-time expenses.

Revenue increased 7% YoY to $437,392,000, driven by growth in Cardio & Vascular segment.

Adjusted EPS rose to $1.31, up from $1.14 in Q1 2024.

GAAP Net Loss was $22,465,000 primarily due to debt conversion inducement expenses.

Adjusted operating income grew 14% YoY to $70,923,000.

Total Revenue
$437M
Previous year: $415M
+5.4%
EPS
$1.31
Previous year: $1.14
+14.9%
Free Cash Flow
$31.3M
Previous year: $23.2M
+34.6%
Gross Profit
$120M
Previous year: $100M
+19.9%
Cash and Equivalents
$31.7M
Previous year: $42.2M
-24.8%
Free Cash Flow
$31.3M
Previous year: -$5.83M
-636.2%
Total Assets
$3.3B
Previous year: $3.12B
+5.8%

Integer

Integer

Integer Revenue by Segment

Forward Guidance

Integer reaffirmed 2025 sales and adjusted operating income guidance and raised adjusted EPS outlook, expecting continued momentum.

Positive Outlook

  • Raised adjusted EPS guidance to $6.15–$6.51.
  • Expected sales growth of 8% to 10% for full-year 2025.
  • Forecasted adjusted operating income growth of 11% to 16%.
  • Anticipated adjusted EBITDA range of $401M to $422M.
  • Expected $13M reduction in interest expense due to 2030 convertible notes.

Challenges Ahead

  • GAAP income from continuing operations projected to decline YoY.
  • Diluted GAAP EPS expected to decline by 4% to 14%.
  • Leverage ratio increased to 3.3x adjusted EBITDA due to acquisitions.
  • Total debt rose by $245M to finance M&A activity.
  • Convertible debt transactions may lead to potential equity dilution.

Revenue & Expenses

Visualization of income flow from segment revenue to net income